Opioid | | Uptake inhibition | 7–14 |
Cocaine | | Uptake inhibition | 7–14 |
Tramadol | | Uptake inhibition | 7–14 |
Tricyclic antidepressants | Amitriptyline and derivatives, imipramine and derivatives, amoxapine, doxepin, others | Uptake inhibition | 7–21 |
Sympathicomimetics
*
| Phenylpropanolamine, ephedrine, pseudoephedrine, phenylephrine, amphetamine, dopamine, isoproterenol, salbutamol, terbutaline, fenoterol, xylometazoline | Depletion of granules | 7–14 |
Antihypertensive or cardiovascular agents | Labetalol | Inhibition of uptake and depletion | 21 |
| Reserpine | Depletion and transport inhibition | 14 |
| Bretylium, guanethidine | Depletion and transport inhibition | 14 |
| Calcium channel blockers (nifedipine, nicardipine, amlodipine) | Increased uptake and retention | 14 |
Antipsychotics | Phenothiazines
†
(chlorpromazine, promethazine, fluphenazine, others) | Uptake inhibition | 21–28 |
| Thioxanthenes (maprotiline, trazodone) | Uptake inhibition | 21–28 |
| Butyrophenones (droperidol, haloperidol) | Uptake inhibition | 21–28 |
| Loxapine | Uptake inhibition | 7–21 |